← FDA Drug Approvals (Drugs@FDA)

ABACAVIR; LAMIVUDINE

NDA · New Drug Application · Sponsor: HETERO LABS LTD V · Approved 2015-11-13

Drug application

FDA Application #

NDA207369

Application type

New Drug Application

Brand name

ABACAVIR; LAMIVUDINE

Generic name

Abacavir

Active ingredients

ABACAVIR; LAMIVUDINE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

HETERO LABS LTD V

First approval

2015-11-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown